Nebracetam (WEB 1881FU) Prevents N-Methyl-D-Aspartate Receptor-Mediated Neurotoxicity in Rat Striatal Slices

Kataoka, Yasufumi; Níwa, Masami; Koizumi, Satoshi; Watanabe, Soichi; Kouzuma, Masami; Taniyama, Kohtaro

doi:10.1254/jjp.59.247

Cited by 5 publications

(2 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This evidence supports our previous notion that nebracetam may be useful for the treatment of hypoxic/ischemic brain injury (8,9).…”

Section: Introductionsupporting

confidence: 91%

“…Excessive Ca 2+ entry, an etiological event of neuronal injury, occurs largely through Ca 21 channels gated by the N-methyl-D-aspartate (NMDA) receptor, a subtype of the glutamate receptor, but also through voltage-gated Ca 21 channels (VGCC) (14). Nebracetam induced significant recovery from striatal dopaminergic impairment induced by L-glutamate and NMDA, but did not protect against that induced by BAY K 8644, an L-type VGCC agonist (9). These findings suggested that nebracetam possessed the ability to protect against striatal dysfunction by inhibiting an inappropriate Ca2+ influx through NMDA receptor-gated Ca 21 channels.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Histological Evidence for Neuroprotective Action of Nebracetam on Ischemic Neuronal Injury in the Hippocampus of Stroke-Prone Spontaneously Hypertensive Rats

Nakashima

Kataoka

Yamashita

et al. 1995

Japanese Journal of Pharmacology

Self Cite

View full text Add to dashboard Cite

ABSTRACT-Theprotective effect of nebracetam on ischemic neuronal damage was histologically examined in the pyramidal cell layer of the hippocampal CAI subfield 7 days after operation using stroke-prone spontaneously hypertensive rats (SHRSP) subjected to 10-min bilateral carotid occlusion. Nebracetam (50 and 100 mg/kg), given orally 10 min after reperfusion, dose-dependently protected against ischemic delayed neuronal damage in the SHRSP with occlusion; however, the blood pressure remained unchanged following nebracetam administration. These findings further support the notion that nebracetam protects against ischemic delayed neuronal cell death in the hippocampus. Keywords:Nebracetam, Ischemic hippocampal damage, Stroke-prone spontaneously hypertensive rat *To whom correspondence should be addressed .Stroke-prone spontaneously hypertensive rats (SHRSP) are a genetically determined hypertensive strain derived from spontaneously hypertensive rats (1). When these animals are fed a high-salt diet, severe hypertension occurred and their life span was short because of end-organ damage (1). The SHRSP are useful for evaluating the potency and therapeutic value of antihypertensive agents (2, 3). We demonstrated that 10-min bilateral carotid occlusion in SHRSP gradually decreased the density of the pyramidal cells in the hippocampal CAI subfield and neuronal cell death reached a peak 7 days after the operation (4, 5). This two-vessel occlusion model of SHRSP has advantages over the four-vessel occlusion model of normal rats (6) because it avoids the coagulation of bilateral vertebral arteries. This point leads to the different dynamics of cerebral blood flow after reperfusion between our model and the four-vessel occlusion model. In this context, our model more closely simulated the post-ischemic conditions in humans. Therefore, the SHRSP with twovessel occlusion is useful for examining delayed neuronal cell death in the hippocampus caused by a transient forebrain ischemia (4, 5). Several lines of evidence have shown that nebracetam has a nootropic property (7 -12).This compound protected against hypoglycemia/hypoxiainduced striatal and hippocampal damages in vitro (8 -10) and decreased the disruption of spatial cognition and memory impairment evoked by various treatments in vivo (11,12). The present study histologically examined the protective effects of nebracetam against ischemic hippocampal neuronal damage using the two-vessel occlusion model of SHRSP. Male SHRSP maintained and bred at the Laboratory Animal Center for Biochemical Research, Nagasaki University School of Medicine were used. These animals were fed a high-salt and low-protein diet containing 0.8% NaCI and 20.8% of protein (Funabashi Farm Co., Chiba) and allowed water ad libitum. Three to four rats per group were housed in a cage in an air-conditioned room at 24 ± I °C , humidity of 65 _±:5 %, with a 12-hr light-dark schedule (lights on 7:00 a.m.). Twelve-to fourteen-weekold SHRSP, each weighing 260-290 g, were supplied for bilateral carotid occlusion. Ne...

show abstract

“…This evidence supports our previous notion that nebracetam may be useful for the treatment of hypoxic/ischemic brain injury (8,9).…”

Section: Introductionsupporting

confidence: 91%

Section: Introductionmentioning

confidence: 99%